Home › Funds › Citigroup Inc › PCVX
Citigroup Inc position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)202.67K sh
Reported value held$11.78M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 25.27K | $641.00K | New |
| Q4 2021 | 46.43K | $1.10M | Add |
| Q1 2022 | 12.38K | $299.00K | Reduce |
| Q2 2022 | 56.07K | $1.22M | Add |
| Q3 2022 | 161.64K | $3.88M | Add |
| Q4 2022 | 124.97K | $5.99M | Reduce |
| Q1 2023 | 148.09K | $5.55M | Add |
| Q2 2023 | 78.62K | $3.93M | Reduce |
| Q3 2023 | 95.44K | $4.87M | Add |
| Q4 2023 | 78.91K | $4.96M | Reduce |
| Q1 2024 | 144.87K | $9.90M | Add |
| Q2 2024 | 165.79K | $12.52M | Add |
| Q3 2024 | 220.54K | $25.20M | Add |
| Q4 2024 | 404.21K | $33.09M | Add |
| Q1 2025 | 621.08K | $23.45M | Add |
| Q2 2025 | 489.08K | $15.90M | Reduce |
| Q3 2025 | 313.08K | $11.28M | Reduce |
| Q4 2025 | 241.88K | $11.16M | Reduce |
| Q1 2026 | 132.18K | $7.68M | Reduce |
| Q2 2026 | 202.67K | $11.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026